Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check23 days agoChange DetectedA sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference0.7%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe ClinicalTrials.gov footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now shows a new revision, v3.7.0, replacing the previous v3.6.6. This indicates an update to the study record.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history shows an updated revision tag: v3.6.6 replaces the previous v3.6.5, indicating a metadata update to the study record. No substantive study data or content appears to be changed.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.